Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects.
Tóm tắt
Từ khóa
Tài liệu tham khảo
Inman WHW, Adelstein AM. Rise and fall of asthmiia mortality in England and Wales in relation to use of pressurised aerosols. Lanc et 1969;2:279-85.
Campbell AH. Morta!ity from asthma and bronchodilator aerosols. MedJ Aiost 1976;1:386-91.
Conolly ME, Davies DS, Dollery CT, George CF. Resistance to beta-adrenoceptor stimulants (a possible explanation for the rise in asthma deaths). Br J Plharniacol 1971;43:389-402.
Van Metre TE. Adverse effects of inhalation of excessive amounts of nebulised isoproterenol in status asthmaticus. J Allergy 1969;43:101-13.
Larsson S, Svedmyr N, Thiringer G. Lack of bronchial beta adrenoceptor resistance in asthmatics during long term treatment with terbutaline. J Allergv Clin lImtlntiol 1977;59:93-100.
Holgate ST, Stubbs WA, Wood PJ, McCaughey ES, Alberti KGMM, Tattersfield AE. Airway and metabolic resistance to intravenous salbutamol: a study in normal man. Clin Sci 1980;59:155-61.
Nelson HS, Black JW, Branch LB et al. Subsensitivity to epinephrine following the administration of epinephrine and ephedrine to normal individuals. J Allergy, Clini Immunol 1975;55:299-309.
Jenne JW, Chick TW, Strickland RD, Wall FJ. Subsensitivity of beta responses during therapy with a longacting beta-2 preparation. J Allergy Clin Inmuiinnol 1977; 59:383-90. " Paterson JW, Conolly ME, Davies DS, Dollery CT.
Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet 1968;2:426-9.
Morris HG, Rusnak SA, Selner JC, Barzens K, Barnes J. Comparative effects of ephedrine on adrenergic responsiveness in normal and asthmatic subjects. J Allergy Clin Immunol 1978;61:294-302.
Greenacre JK, Schofield P, Conolly ME. Desensitization of the /-adrenoceptor of lymphocytes from normal subjects and asthmatic patients in vitro. Br J Clin Pharmacol 1978;5:199-206.
Parker CW, Smith JW. Alterations in cyclic adenosinie monophosphate metabolism in human bronchial asthma. J Clin Invest 1973;52:48-59.
Gibson GJ, Tattersfield AE, Pride NB. The effects of oral salbutamol on response to inhaled isoprenaline in asthmatic subjects. Bull Physiopathol Respir 1972;8: 657-8.
Formgren H. The therapeutic value of oral long termii treatment with terbutaline (Bricanyl]R) in asthma. A follow up study of its efficacy and side effects. Scand J Respir Dis 1975;56:321-8.
Wilson AF, Novey HS, Cloninger P, Davis J, White D. Cardiopulmonary effects of long-term bronchodilator administration. J Allergy Clin Immunol 1976;58:204-12.
Peel ET, Gibson GJ. Effects of long-term inhaled salbutamol therapy on the provocation of asthma by histamine. Am Rev Respir Dis 1980;121:973-8.
Miller J, Wallace D, Grieco MH, Frenkel R, Larsen K. Double-blind trial of oral carbuterol in bronchial asthma. Ann Allergy 1977;39:12-17.
Plummer AL. The development of drug tolerance to beta2 adrenergic agents. Chest 1978;73:949-57. Suppl.
Gibson GJ, Greenacre JK, Konig P, Conolly ME, Pride NB. Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthma. Br J Dis Chest 1978;72:199-206.
Holgate ST, Baldwin CJ, Tattersfield AE. ft-adrenergic agonist resistance in normal human airways. Lancet 1977;2:375-7.
Tattersfield AE, Keeping IM. Assessing change in airway calibre-measurement of airway resistance. Br J Clin Pharmacol 1979;8:307-19.
Harvey JE, Baldwin CJ, Wood PJ, Alberti KGMM, Tattersfield AE. Airway and metabolic responsiveness to intravenous saibutamol in asthma: effect of regular inhaled salbutamol. Clin Sci 1981;60:579-85.
Van Arsdel PP, Schaffrin RM, Rosenblatt J, Sprenkle AC, Altman LC. Evaluation of oral fenoterol in chronic asthmatic patients. Chest 1978;73:997-8. Suppl.
Gallagher JT, Kent PW, Passatore M, Phipps RJ, Richardson PS. The composition of tracheal mucus and the nervous control of its secretion in the cat. Proc R Soc Lond(Biol) 1975;192:49-76.
Williams IP, Phipps RJ, Wright NL, Pack RJ, Richardson PS. Sympathomimetic agonists stimulate mucus secretion into human bronchi. Thorax 1981;36:231(abstr).
Orange RP, Austen WG, Austen KF. Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3'5'-adenosine monophosphate. J Exp Med 1971;134:136s-48s.
Fuller DJM, Byus CV, Russell DH. Specific regulation by steroid hormones of the amount of type 1 cyclic-AMP dependent protein kinase holoenzyme. Proc Nati Acad Sci USA 1978;75:223-7.
Brooks SM, McGowan K, Bernstein IL, Altenau P, Peagler J. Relationship between numbers of betaadrenergic receptors in lymphocytes and disease severity in asthma. J Allergy Clin Immunol 1979;63:401-6.
Szentivanyi A. The radioligand binding approach in the study of lymphocytic adrenoceptors and the constitutional basis of atopy. J Allergy Clin Immunol 1980; 65:5-11.
Barnes PJ, Dollery CT, MacDermot J. Increased pulmonary a-adrenergic and reduced,B-adrenergic receptors in experimental asthma. Nature 1980;285:569-71.
Galant SP, Duriseti L, Underwood S, Allred S, Insel PA. Beta-adrenergic receptors of polymorphonuclear particulates in bronchial asthma. J Clin Invest 1980;65: 577-85.
Mukherjee C, Caron MG, Lefkowitz RJ. Regulation of adenylate cyclase coupled beta-adrenergic receptors by beta-adrenergic catecholamines. Endocrinology 1976;99: 347-57.